Kyle A Perry: Clinical Trials

1 trial sponsored by Kyle A Perry, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Kyle A Perry: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
Reletex, IV ondansetron 4 mg q 6 hours for a total of 4 doses, IV promethazine 25 mg q 6 hours prn - Nausea and Vomiting Post-foregut Surgery
Not applicableCompletedKyle A Perry1002011-08-012014-03-05

Conditions studied

Nausea (1)  ·  Vomiting (1)

Interventions

Ondansetron (1)  ·  Promethazine (1)

Countries

United States (1)

Top investigators

Kyle Perry, MD (1)